What does optimal outreach, early detection, and preventive care for breast cancer look like? As a key member of two large research consortia focused on improving cancer screening and outcomes, Diana Buist is in a prime position to help answer this important question.
Dr. Buist is an epidemiologist and health services researcher whose work focuses primarily on early detection of breast cancer and reducing illness and death from breast cancer in populations. She is especially interested in translating research findings into clinically meaningful guidelines. Dr. Buist joined Group Health Research Institute (GHRI) in 1996 and within a few years became the Principal Investigator of the Group Health Breast Cancer Surveillance Project, one of seven sites participating in the National Cancer Institute's Breast Cancer Surveillance Consortium. She has also played a key role in several collaborative projects conducted by the HMO Cancer Research Network.
Her extensive experience working with these diverse data in longitudinal studies and randomized trials puts Dr. Buist in a unique position to examine cancer screening, care, and outcomes in health systems across the country. Because of her particular expertise in this area, she recently became a member of the Group Health-affiliated Evidence-based Practice Center—one of 11 centers funded by the Agency for Healthcare Research and Quality in 2012. Her role will include conducting systematic reviews for the U.S. Preventive Services Task Force.
Dr. Buist is an affiliate investigator at the Fred Hutchinson Cancer Research Center and an affiliate professor in the Departments of Epidemiology and Health Services at the University of Washington School of Public Health. She is also a senior scholar in residence at AcademyHealth. She enjoys sharing her expertise by mentoring junior faculty and PhD and MPH candidates, co-directing the CRN Scholars Program, and teaching courses in clinical outcomes research internationally through the American Thoracic Society.
Cancer screening and prevention; outreach and primary care prevention; comparative effectiveness; cost transparency; surveillance; secondary prevention; breast cancer treatment; breast cancer screening; outcomes following cancer diagnosis; cancer survivorship; provider variability in care
Cancer prevention and control; quality of care; preventive care; high-value care; consumer engagement in preventive medicine; systematic reviews
Cancer prevention and control
Owens CL, Buist DS, Peterson D, Kamineni A, Weinmann S, Ross T, Williams AE, Stark A, Adams KF, Doubeni CA, Field TS.Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.
Cancer Cytopathol. 2014 Oct 23. doi: 10.1002/cncy.21490 [Epub ahead of print]. PubMed
Beaber EF, Buist DS, Barlow WE, Malone KE, Reed SD, Li CI.Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
Cancer Res. 2014;74(15):4078-89. doi: 10.1158/0008-5472.CAN-13-3400. PubMed
Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N.Cancer risk awareness and concern among women with a family history of breast or ovarian cancer.
Behav Med. 2014 Jul 25:0 [Epub ahead of print]. PubMed
Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM.Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.
Breast Cancer Res Treat. 2014;146(2):401-9. doi: 10.1007/s10549-014-3021-8. Epub 2014 Jun 18. PubMed
Buist DS, Anderson ML, Smith RA, Carney PA, Miglioretti DL, Monsees BS, Sickles EA, Taplin SH, Geller BM, Yankaskas BC, Onega TL.Effect of radiologists' diagnostic work-up volume on interpretive performance.
Radiology. 2014 Jun 24:132806 [Epub ahead of print]. PubMed
Geller BM, Bogart A, Carney PA, Sickles EA, Smith RA, Monsees B, Bassett LW, Buist DM, Kerlikowske K, Onega T, Yankaskas B, Haneuse S, Hill DA, Wallis M, Miglioretti DL.Educational interventions to improve screening mammography interpretation: a randomized, controlled trial.
AJR Am J Roentgenol. 2014 Jun;202(6):W586-96. doi: 10.2214/AJR.13.11147.
Onega T, Hubbard R, Hill D, Lee C, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske D, Virnig BA, Buist DS, Henderson L, Tosteson A.Geographic access to breast imaging for U.S. women.
J Am Coll Radiol. 2014 May 30. pii: S1546-1440(14)00161-6. doi: 10.1016/j.jacr.2014.03.022. [Epub ahead of print].
Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.Benefits, harms and costs for breast cancer screening in the U.S. following implementation of digital mammography.
J Natl Cancer Inst. 2014 May 28;106(6). pii: dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.
Henrikson N, Tuzzio L, Loggers ET, Miyoshi J, Buist DS.Patient and oncologist discussions about cancer care costs.
Support Care Cancer. 2014 Apr;22(4):961-7. doi: 10.1007/s00520-013-2050-x. Epub 2013 Nov 26. PubMed
Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS.Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Breast Cancer Res Treat. 2014 Apr;144(2):405-16. doi: 10.1007/s10549-014-2870-5. Epub 2014 Feb 21. PubMed
For Breast Cancer Awareness Month, Dr. Diana Buist tells how Group Health research helps women and their doctors decide if, when, and how to screen.
Seattle Times, Sep. 30, 2014